COMMD1通过NF-κB通路调节Talaromyces marneffei诱导的骨髓炎中的骨质细胞分化
Yi Zhang1, Fayun Yang1, Weilun Zhao2
1Department of Spine Osteopathia, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.
Infection and drug resistance
|November 27, 2025
概括
铜代谢蛋白COMMD1通过抑制NF-κB通路来保护抗Talaromyces marneffei诱导的骨髓炎. 缺少COMMD1会加剧骨的破坏,突出显示了它对骨感染的治疗潜力.
科学领域:
- 传染性疾病 传染性疾病
- 骨生物学 骨生物学 骨生物学
- 分子生物学分子生物学
背景情况:
- 塔拉罗米切斯马尔内菲 (TM) 感染可能导致骨髓炎 (OM),导致骨严重损伤.
- 背后的精确分子机制TM诱导的OM和骨损坏仍然不完全理解.
- 铜代谢及其调节者,如COMMD1,可能在传染性骨疾病中发挥作用.
研究的目的:
- 调查铜代谢MURR1域含有1 (COMMD1) 在Talaromyces marneffei (TM) 诱导的骨髓炎 (OM) 中的作用.
- 阐明COMMD1通过NF-κB途径对骨质细胞分化的调节.
- 评估COMMD1作为潜在的治疗目标,治疗骨感染.
主要方法:
- 建立了一种小鼠TM感染模型,用微型CT,组织学和生物力学测试来评估骨破坏和骨质细胞活性.
- 采用RNA测序来识别TM感染骨中的差异表达基因.
- 利用COMMD1条件淘汰赛 (cKO) 小鼠和骨髓衍生的巨细胞进行功能验证,并通过JSH-23抑制NF-κB以确认通路依赖性.
主要成果:
- TM感染导致严重的骨结构损伤,炎症性细胞因子增加,骨质细胞分化标志物升高.
- 在感染TM的小鼠中,RNA测序揭示了COMMD1下调和NF-κB通路激活.
- 缺少COMMD1会加剧骨破坏和骨质细胞形成,而过度表达COMMD1会抑制这些效应,这与调节NF-κB通路有关.
结论:
- COMMD1 具有保护性作用,可以抵抗 Talaromyces marneffei 引起的骨髓炎.
- 通过抑制NF-κB通路,COMMD1抑制骨质细胞分化.
- COMMD1代表了一种有前途的治疗点,用于治疗骨感染.
更多相关视频
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K
Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K


